REGENXBIO Inc

(NASDAQ:RGNX)

Latest On REGENXBIO Inc (RGNX):

Date/Time Type Description Signal Details
2023-05-23 17:08 ESTNewsRegenxbio's gene therapy for Hunter syndrome gets FDA regenerative medicine statusN/A
2023-05-12 13:54 ESTNewsRegenxbio: Buy, High-Potential Stock Stagnant Due To No Near-Term CatalystsN/A
2023-05-04 03:36 ESTNewsRegenxbio GAAP EPS of -$1.53 misses by $0.14, revenue of $19.14M misses by $12.15MN/A
2023-05-04 03:36 ESTNewsREGENXBIO Inc. (RGNX) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 02:13 ESTNewsRegenxbio Q1 2023 Earnings PreviewN/A
2023-04-11 18:11 ESTNewsRegenxbio stock pops on FDA fast track tag for Duchenne gene therapy RGX-202N/A
2023-03-01 00:46 ESTNewsRegenxbio GAAP EPS of -$1.38 beats by $0.05, revenue of $31.35M misses by $6.1MN/A
2023-03-01 00:46 ESTNewsREGENXBIO Inc. (RGNX) Q4 2022 Earnings Call TranscriptN/A
2023-02-27 19:10 ESTNewsRegenxbio Q4 2022 Earnings PreviewN/A
2023-02-22 17:10 ESTNewsRegenxbio's Vector Technology Will Change Gene TherapyN/A
2023-02-22 17:09 ESTNewsRegenxbio touts interim results from trial of pediatric rare disease gene therapyN/A
2023-02-17 07:13 ESTNewsRegenxbio: Flat Price Response To Key Catalysts Confirms HoldN/A
2023-02-13 10:49 ESTNewsRegenxbio's study shows similar clinical profile of eye drug produced via different methodsN/A
2023-01-23 18:57 ESTNewsRegenxbio begins phase 1/2 trial of Duchenne muscular dystrophy candidateN/A
2023-01-10 13:38 ESTNewsRegenxbio names Curran Simpson as COON/A
2022-11-21 14:24 ESTNewsRegenxbio: Great R&D, Lack Of Near-Term CatalystsN/A
2022-11-04 07:46 ESTNewsREGENXBIO Inc. (RGNX) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 14:46 ESTNewsRegenxbio GAAP EPS of -$1.75 misses by $0.26, revenue of $26.5M misses by $4.31MN/A
2022-11-03 14:45 ESTNewsRegenxbio slumps 17% as Q3 Zolgensma royalty revenue falls, net loss widensN/A
2022-11-02 06:09 ESTNewsRegenxbio Q3 2022 Earnings PreviewN/A
2022-10-03 15:46 ESTNewsREGENXBIO says additional phase 2 data bolsters RGX-314 for wet macular degenerationN/A
2022-10-01 15:17 ESTNewsStocks To Watch: Investors Look For Edges Amid Inflation, Rates, Earnings ChallengesN/A
2022-09-15 21:34 ESTNewsRegenxbio: A Transformative YearN/A
2022-08-31 18:25 ESTNewsREGENXBIO shares more data for Hunter Syndrome candidateN/A
2022-08-29 17:41 ESTNewsRegenxbio: Updates To Thesis, Gene Therapy Pioneer Moving To Late-Stage DevelopmentN/A
2022-08-05 07:16 ESTNewsREGENXBIO Inc. (RGNX) CEO Ken Mills on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 01:21 ESTNewsRegenxbio GAAP EPS of -$1.58 misses by $0.14, revenue of $32.65M beats by $5.87MN/A
2022-08-03 10:18 ESTNewsRegenxbio to seek FDA's accelerated approval for Hunter Syndrome treatment, shares rise 8%N/A
2022-08-02 20:22 ESTNewsREGENXBIO (RGNX) Investor Presentation - SlideshowN/A
2022-08-02 20:21 ESTNewsRegenxbio Q2 2022 Earnings PreviewN/A
2022-07-13 05:59 ESTNewsRegenxbio: Patience And Regular Homework Are KeysN/A
2022-06-23 19:14 ESTNewsBerenberg initiates coverage on Regenxbio with buy ratingN/A
2022-06-12 03:09 ESTNewsWith bluebird bio's success, what are other gene therapies companies to pay attention to?N/A
2022-06-10 02:15 ESTNewsRegenxbio opens new gene therapy manufacturing facility in MarylandN/A
2022-05-14 22:40 ESTNewsStocks To Watch: Retail Heavyweights Report, Block And Moderna EventsN/A
2022-05-05 09:02 ESTNewsRegenxbio GAAP EPS of -$1.79 misses by $0.49, revenue of $22.2M misses by $7.01MN/A
2022-05-05 09:02 ESTNewsREGENXBIO Inc. (RGNX) CEO Ken Mills on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 19:54 ESTNewsRegenxbio Q1 2022 Earnings PreviewN/A
2022-04-20 18:04 ESTNewsRegenxbio: Is The Ultimate Catalyst Coming?N/A
2022-03-08 19:04 ESTNewsRegenxbio: Suprachoroidal Data Is Still The KeyN/A
2022-03-02 22:40 ESTNewsRegenxbio gains the most in five months on the launch of “5x25 strategy”N/A
2022-03-02 05:58 ESTNewsRegenxbio GAAP EPS of $6.67 beats by $2.93, revenue of $398.65M beats by $142.89MN/A
2022-03-02 05:58 ESTNewsRegenxbio stock unchanged after hours despite bottom and top line beatsN/A
2022-03-02 05:58 ESTNewsREGENXBIO's (RGNX) CEO Ken Mills on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 17:57 ESTNewsRegenxbio Q4 2021 Earnings PreviewN/A
2022-02-09 17:46 ESTNewsREGENXBIO posts early data from Phase I/II trial for RGX-111 in MucopolysaccharidosisN/A
2022-01-06 17:34 ESTNewsRegenxbio on go with mid-stage RGX-202 trial for Duchenne muscular dystrophyN/A
2021-12-27 00:45 ESTNewsRegenxbio: Accumulating For The Long HaulN/A
2021-12-22 23:21 ESTNewsCitizen Petition asks FDA to block Regenxbio patent extension for ZolgensmaN/A
2021-11-23 07:18 ESTNewsOrphan Drug Designation granted for REGENXBIO Duchennne muscular dystrophy treatmentN/A

About REGENXBIO Inc (RGNX):

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II; RGX-111, which is in Phase I clinical trial for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease; and RGX-501, which is in Phase I/II clinical trials to treat homozygous familial hypercholesterolemia. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop vectorized antibodies for the treatment of neurodegenerative diseases. The company was formerly known as ReGenX Biosciences, LLC and changed its name to REGENXBIO Inc. in September 2014. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.

See Advanced Chart

General

  • Name REGENXBIO Inc
  • Symbol RGNX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 306
  • Fiscal Year EndDecember
  • IPO Date2015-09-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.regenxbio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 9.47
  • Price/Book (Most Recent Quarter) 4.42
  • Enterprise Value Revenue 8.19
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$5.06
  • Next Year EPS Estimate -$5.20
  • Next Quarter EPS Estimate -$1.32
  • Profit Margin -72%
  • Operating Margin -77%
  • Return on Assets -12%
  • Return on Equity -27%
  • Revenue 154.57 million
  • Earnings Per Share -$1.36
  • Revenue Per Share $4.15
  • Gross Profit -47441000
  • Quarterly Earnings Growth 82.2%
View More

Highlights

  • Market Capitalization 1.78 billion
  • EBITDA -87438000
  • PE Ratio -2.51
  • PEG Ratio 0.26
  • Analyst Target Price $63.22
  • Book Value Per Share $10.08
View More

Share Statistics

  • Shares Outstanding 42.5 million
  • Shares Float 36.95 million
  • % Held by Insiders 1454%
  • % Held by Institutions 89.9%
  • Shares Short 2.94 million
  • Shares Short Prior Month 2.66 million
  • Short Ratio 7.52
  • Short % of Float 10%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.2
  • 52 Week High $50.26
  • 52 Week Low $25.93
  • 50 Day Moving Average 42.78
  • 200 Day Moving Average 37.27
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

REGENXBIO Inc (RGNX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

REGENXBIO Inc (RGNX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$21.45 million-$1.24-$1.17-6.28%
2020-09-302020-11-04$N/A$0.23-$0.89125.73%
2020-06-302020-08-06$N/A-$0.91-$0.85-6.81%
2020-03-312020-05-07$17.64 million-$1.08-$0.87-24.86%
2019-12-312020-02-26$11.77 million-$0.72-$0.40-78.53%
2019-09-302019-11-05$14.7 million-$0.94-$0.91-3.67%
2019-06-302019-08-07$7.88 million-$0.04-$0.7594.64%
2019-03-312019-05-07$884000-$0.89-$0.85-5.11%
2018-12-312019-02-27$40.78 million$0.11-$0.34132.67%
2018-09-302018-11-07$5.31 million-$0.56-$0.8634.88%
2018-06-302018-08-08$40.03 million$0.30$1.23-75.61%
2018-03-312018-05-08$132.39 million$3.04$1.6090.6%
2017-12-312018-03-06$2.04 million-$0.51-$0.8237.42%
2017-09-302017-11-08$1.34 million-$0.67-$0.726.94%
2017-06-302017-08-08$6.56 million-$0.47-$0.8041.25%
2017-03-312017-05-09$455000-$0.82-$0.76-8.37%
2016-12-312017-03-07$1.7 million-$0.74-$0.60-24.37%
2016-09-302016-11-09$125000-$0.69-$0.60-15%
2016-06-302016-08-09$2.38 million-$0.55-$0.52-6.8%
2016-03-312016-05-05$393000-$0.41-$0.458.89%
2015-12-312016-03-03$4.44 million-$0.20-$0.3339.39%
2015-09-302015-11-05$1.15 million-$1.52

REGENXBIO Inc (RGNX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

REGENXBIO Inc (RGNX) Chart:

REGENXBIO Inc (RGNX) News:

Below you will find a list of latest news for REGENXBIO Inc (RGNX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

REGENXBIO Inc (RGNX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.50CALL0 0350.42TRUE00
2025-04-1751.85CALL0 2258.22TRUE00
2025-04-177.50.97CALL0 13746.28TRUE00
2025-04-17100.1CALL1 47588.57FALSE00
2025-04-1712.50.1CALL0 206217.43FALSE00
2025-04-17150.15CALL0 32483.93FALSE00
2025-04-1717.50.01CALL0 23523.88FALSE00
2025-04-17200.05CALL0 25556.63FALSE00
2025-04-1722.50.25CALL0 32584.29FALSE00
2025-04-172.50PUT0 0292.46FALSE00
2025-04-1750.2PUT0 4129.09FALSE00
2025-04-177.50.33PUT22 25669.39FALSE0.030.1
2025-04-17101.95PUT0 42154.23TRUE00
2025-04-1712.54.04PUT0 40178.76TRUE00
2025-04-17154.8PUT0 1233.3TRUE00
2025-04-1717.58.4PUT0 0328.55TRUE00
2025-04-17209.7PUT0 1434.6TRUE00
2025-04-1722.510.86PUT0 0385.53TRUE00
2025-05-162.50CALL0 0216.91TRUE00
2025-05-1650CALL0 0100.94TRUE00
2025-05-167.50CALL0 0209.22TRUE00
2025-05-16100.5CALL1 0101.43FALSE0.50
2025-05-1612.50CALL0 0285.02FALSE00
2025-05-16150CALL0 0312.71FALSE00
2025-05-162.50PUT0 0867.47FALSE00
2025-05-1650PUT0 0383.18FALSE00
2025-05-167.50.6PUT0 1183.7FALSE00
2025-05-16100PUT0 083.53TRUE00
2025-05-1612.50PUT0 092.16TRUE00
2025-05-16150PUT0 0348.04TRUE00
2025-07-182.54.6CALL0 4230.28TRUE00
2025-07-1853.9CALL0 3135.21TRUE00
2025-07-187.51.5CALL5 37076.66TRUE1.50
2025-07-18101.32CALL0 23868.92FALSE00
2025-07-1812.50.36CALL0 1990.59FALSE00
2025-07-18150.5CALL0 3299.49FALSE00
2025-07-1817.50.7CALL0 3158.24FALSE00
2025-07-18200CALL0 0169.66FALSE00
2025-07-1822.50.08CALL0 37258.16FALSE00
2025-07-182.50PUT0 0669.48FALSE00
2025-07-1850.55PUT0 691.27FALSE00
2025-07-187.51.03PUT5 6473.63FALSE-0.07-0.06
2025-07-18102.49PUT0 1175.9TRUE00
2025-07-1812.54.5PUT0 51106.25TRUE00
2025-07-18158.3PUT0 099.97TRUE00
2025-07-1817.50PUT0 0132.83TRUE00
2025-07-18200PUT0 0133.53TRUE00
2025-07-1822.50PUT0 0177.1TRUE00
2025-10-172.50CALL0 0168.46TRUE00
2025-10-1750CALL0 0110.42TRUE00
2025-10-177.52CALL0 4037.89TRUE00
2025-10-17101.15CALL0 35779.97FALSE00
2025-10-1712.51.17CALL0 30071.49FALSE00
2025-10-17150.33CALL0 2577.59FALSE00
2025-10-172.50PUT0 0761.98FALSE00
2025-10-1750.54PUT0 6123.58FALSE00
2025-10-177.51.25PUT0 33469.69FALSE00
2025-10-17102.9PUT0 35266.7TRUE00
2025-10-1712.54.54PUT0 984.58TRUE00
2025-10-17150PUT0 087.83TRUE00

Latest RGNX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST7$19.69
Jun 13, 2022 7:59 PM EST1$19.68
Jun 13, 2022 7:59 PM EST1$19.68
Jun 13, 2022 7:59 PM EST12$19.68
Jun 13, 2022 7:59 PM EST6$19.67

REGENXBIO Inc (RGNX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312520185954/0001193125-20-185954-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000009375119000165/0000093751-19-000165-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000009375120000551/0000093751-20-000551-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000021545719002614/0000215457-19-002614-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000031506619001295/0000315066-19-001295-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000083423720002781/0000834237-20-002781-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000089924320025725/0000899243-20-025725-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000093247119005789/0000932471-19-005789-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000110465920017826/0001104659-20-017826-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000110465920021827/0001104659-20-021827-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312518319055/0001193125-18-319055-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312519001555/0001193125-19-001555-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000119312519040856/0001193125-19-040856-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1590877/000119312519103878/0001193125-19-103878-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1590877/000119312519103879/0001193125-19-103879-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312519164137/0001193125-19-164137-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312519266891/0001193125-19-266891-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312520004236/0001193125-20-004236-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000119312520035624/0001193125-20-035624-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000119312520035640/0001193125-20-035640-index.htm
2020-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000119312520065103/0001193125-20-065103-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312520157279/0001193125-20-157279-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312520185954/0001193125-20-185954-index.htm
2020-09-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1590877/000119312520249155/0001193125-20-249155-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000119312520277495/0001193125-20-277495-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1590877/000149315219001954/0001493152-19-001954-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2018-11-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004476/0001562180-18-004476-index.htm
2018-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm
2018-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004726/0001562180-18-004726-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004775/0001562180-18-004775-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004807/0001562180-18-004807-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004849/0001562180-18-004849-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000218/0001562180-19-000218-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000219/0001562180-19-000219-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000220/0001562180-19-000220-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000221/0001562180-19-000221-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000222/0001562180-19-000222-index.htm
2019-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000337/0001562180-19-000337-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000759/0001562180-19-000759-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019000874/0001562180-19-000874-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019001472/0001562180-19-001472-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019001801/0001562180-19-001801-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019001906/0001562180-19-001906-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm
2019-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002018/0001562180-19-002018-index.htm
2019-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm
2019-04-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002310/0001562180-19-002310-index.htm
2019-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002311/0001562180-19-002311-index.htm
2019-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003180/0001562180-19-003180-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003290/0001562180-19-003290-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003291/0001562180-19-003291-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003292/0001562180-19-003292-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003293/0001562180-19-003293-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003295/0001562180-19-003295-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003296/0001562180-19-003296-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003297/0001562180-19-003297-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003298/0001562180-19-003298-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019004820/0001562180-19-004820-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218019006017/0001562180-19-006017-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000214/0001562180-20-000214-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000216/0001562180-20-000216-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000217/0001562180-20-000217-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000218/0001562180-20-000218-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000219/0001562180-20-000219-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000220/0001562180-20-000220-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000391/0001562180-20-000391-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000452/0001562180-20-000452-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000453/0001562180-20-000453-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm
2020-01-285Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020000618/0001562180-20-000618-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020001013/0001562180-20-001013-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020001014/0001562180-20-001014-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020001108/0001562180-20-001108-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020002850/0001562180-20-002850-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004062/0001562180-20-004062-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004063/0001562180-20-004063-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004064/0001562180-20-004064-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004065/0001562180-20-004065-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004066/0001562180-20-004066-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004069/0001562180-20-004069-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004070/0001562180-20-004070-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020004071/0001562180-20-004071-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1590877/000156218020005162/0001562180-20-005162-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459018028022/0001564590-18-028022-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459018028054/0001564590-18-028054-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459019004898/0001564590-19-004898-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1590877/000156459019004920/0001564590-19-004920-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1590877/000156459019004925/0001564590-19-004925-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459019016503/0001564590-19-016503-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459019016531/0001564590-19-016531-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459019030062/0001564590-19-030062-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459019030100/0001564590-19-030100-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459019040379/0001564590-19-040379-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459019040403/0001564590-19-040403-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459020006781/0001564590-20-006781-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1590877/000156459020006826/0001564590-20-006826-index.htm
2020-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1590877/000156459020006829/0001564590-20-006829-index.htm
2020-04-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1590877/000156459020015913/0001564590-20-015913-index.htm
2020-04-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1590877/000156459020015924/0001564590-20-015924-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459020022854/0001564590-20-022854-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459020022890/0001564590-20-022890-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459020037734/0001564590-20-037734-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459020037775/0001564590-20-037775-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1590877/000156459020050477/0001564590-20-050477-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1590877/000156459020050485/0001564590-20-050485-index.htm
2019-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1590877/999999999719002260/9999999997-19-002260-index.htm
2019-09-23SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1590877/999999999719007068/9999999997-19-007068-index.htm
2019-09-30SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1590877/999999999719007166/9999999997-19-007166-index.htm

REGENXBIO Inc (RGNX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of REGENXBIO Inc (RGNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1454%
Institutional Ownership: 8990%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-01-14DONALD J JR HAYDENDirectorSell30,000.0045.601,368,000.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000391/0001562180-20-000391-index.htm
2020-01-17DONALD J JR HAYDENDirectorSell3,200.0050.01160,032.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000452/0001562180-20-000452-index.htm
2020-02-05DONALD J JR HAYDENDirectorSell2,000.0050.00100,000.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001013/0001562180-20-001013-index.htm
2020-02-10DONALD J JR HAYDENDirectorSell24,800.0050.111,242,728.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001108/0001562180-20-001108-index.htm
2018-11-19LUKE M BESHARDirectorSell600.0063.5338,118.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2018-11-20LUKE M BESHARDirectorSell21,176.0060.381,278,606.880.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2018-11-26LUKE M BESHARDirectorSell1,721.0065.00111,865.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-27LUKE M BESHARDirectorSell18,786.0065.031,221,653.580.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-29LUKE M BESHARDirectorSell12,784.0065.00830,960.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004775/0001562180-18-004775-index.htm
2018-11-05Stephen YooChief Medical OfficerSell4,627.0069.97323,751.190.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2018-11-19Stephen YooChief Medical OfficerSell1,100.0063.2169,531.000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-12-03Stephen YooChief Medical OfficerSell507.0061.2031,028.400.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm
2018-11-19Stephen YooChief Medical OfficerSell800.0061.5549,240.001,100.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-11-27LUKE M BESHARDirectorBuy6,250.0018.85117,812.5011,820.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-19LUKE M BESHARDirectorSell10,916.0060.26657,798.161,200.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2018-11-19LUKE M BESHARDirectorBuy3,262.0012.7441,557.8812,116.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2018-11-05Stephen YooChief Medical OfficerSell4,820.0067.14323,614.8012,181.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2018-12-17Vittal VasistaChief Financial OfficerSell1,700.0047.7481,158.00122,283.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm
2018-12-17Vittal VasistaChief Financial OfficerSell1,700.0046.4778,999.00123,983.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm
2018-12-17Vittal VasistaChief Financial OfficerSell4,100.0045.73187,493.00125,683.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005051/0001562180-18-005051-index.htm
2018-11-29LUKE M BESHARDirectorBuy12,784.003.7648,067.8412,784.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004775/0001562180-18-004775-index.htm
2018-11-15Vittal VasistaChief Financial OfficerSell100.0064.106,410.00129,783.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-11-15Vittal VasistaChief Financial OfficerSell700.0063.0544,135.00129,883.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-11-15Vittal VasistaChief Financial OfficerSell2,042.0062.23127,073.66130,583.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-11-15Vittal VasistaChief Financial OfficerSell588.0060.4035,515.20132,625.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-11-15Vittal VasistaChief Financial OfficerSell1,900.0059.06112,214.00133,213.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-11-15Vittal VasistaChief Financial OfficerSell2,170.0058.46126,858.20135,113.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004611/0001562180-18-004611-index.htm
2018-12-03Stephen YooChief Medical OfficerSell6,854.0059.62408,635.4813,560.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm
2018-11-01Vittal VasistaChief Financial OfficerSell19,677.0070.041,378,177.08137,283.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2018-11-02Vittal VasistaChief Financial OfficerSell53,741.0070.263,775,842.66137,283.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2018-11-01Vittal VasistaChief Financial OfficerBuy9,959.003.7637,445.84147,242.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2018-11-30Olivier DanosChief Scientific OfficerBuy1,500.0020.3530,525.001,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004807/0001562180-18-004807-index.htm
2018-11-19Stephen YooChief Medical OfficerSell2,300.0058.37134,251.0015,353.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-11-01Vittal VasistaChief Financial OfficerBuy9,718.0013.09127,208.62156,960.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2020-02-11Curran SimpsonSVP, Product Development & CTOBuy6,633.0022.00145,926.0016,512.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2018-11-05Stephen YooChief Medical OfficerSell3,413.0066.26226,145.3817,001.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2018-11-02Vittal VasistaChief Financial OfficerBuy32,908.0013.09430,765.72170,191.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2018-11-26LUKE M BESHARDirectorBuy1,721.0049.4585,103.451,721.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-19Stephen YooChief Medical OfficerSell2,761.0057.08157,597.8817,653.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-11-27LUKE M BESHARDirectorBuy6,250.0012.7479,625.0018,070.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-27LUKE M BESHARDirectorBuy716.003.762,692.1618,786.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-19Stephen YooChief Medical OfficerSell4,361.0060.25262,750.251,900.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-11-02Vittal VasistaChief Financial OfficerBuy20,833.0019.50406,243.50191,024.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004417/0001562180-18-004417-index.htm
2020-07-15Vittal VasistaChief Financial OfficerSell14,950.0040.10599,495.00195,024.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020005162/0001562180-20-005162-index.htm
2020-02-05DONALD J JR HAYDENDirectorBuy2,000.000.851,700.002,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001013/0001562180-20-001013-index.htm
2019-01-15Kenneth T. MillsPresident and CEOSell3,140.0044.40139,416.00201,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000337/0001562180-19-000337-index.htm
2018-11-05Stephen YooChief Medical OfficerBuy20,414.000.8517,351.9020,414.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2018-11-19Stephen YooChief Medical OfficerBuy20,414.000.8517,351.9020,414.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2018-12-03Stephen YooChief Medical OfficerBuy20,414.000.8517,351.9020,414.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm
2019-01-15Kenneth T. MillsPresident and CEOSell11,860.0043.70518,282.00204,140.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000337/0001562180-19-000337-index.htm
2020-05-08Vittal VasistaChief Financial OfficerSell7,000.0040.18281,260.00206,715.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm
2020-05-11Vittal VasistaChief Financial OfficerSell500.0040.0020,000.00206,715.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm
2020-05-11Vittal VasistaChief Financial OfficerBuy500.0013.096,545.00207,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm
2020-07-15Vittal VasistaChief Financial OfficerBuy3,259.0013.0942,660.31209,974.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020005162/0001562180-20-005162-index.htm
2020-02-10Vittal VasistaChief Financial OfficerSell14,129.0050.12708,145.48210,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm
2020-04-24Vittal VasistaChief Financial OfficerSell12,000.0040.11481,320.00211,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm
2018-11-20LUKE M BESHARDirectorBuy13,500.003.7650,760.0021,176.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2020-05-08Vittal VasistaChief Financial OfficerBuy2,500.0013.0932,725.00213,715.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003531/0001562180-20-003531-index.htm
2018-12-17Kenneth T. MillsPresident and CEOSell4,408.0047.74210,437.92216,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm
2020-03-31Vittal VasistaChief Financial OfficerBuy10,000.000.858,500.00220,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020002850/0001562180-20-002850-index.htm
2020-04-23Vittal VasistaChief Financial OfficerSell3,000.0040.00120,000.00220,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm
2018-12-17Kenneth T. MillsPresident and CEOSell2,988.0046.81139,868.28220,408.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm
2020-02-05Vittal VasistaChief Financial OfficerSell300.0050.0015,000.00222,021.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001014/0001562180-20-001014-index.htm
2020-01-17Vittal VasistaChief Financial OfficerSell2,394.0050.00119,700.00222,321.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000453/0001562180-20-000453-index.htm
2020-04-23Vittal VasistaChief Financial OfficerBuy3,000.0013.0939,270.00223,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm
2020-04-24Vittal VasistaChief Financial OfficerBuy3,000.0013.0939,270.00223,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020003177/0001562180-20-003177-index.htm
2018-12-17Kenneth T. MillsPresident and CEOSell7,604.0046.11350,620.44223,396.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005050/0001562180-18-005050-index.htm
2020-02-10Vittal VasistaChief Financial OfficerSell677.0049.0533,206.85224,344.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm
2020-01-08Vittal VasistaChief Financial OfficerSell5,100.0041.92213,792.00224,715.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm
2020-02-10Vittal VasistaChief Financial OfficerBuy3,000.0013.0939,270.00225,021.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001111/0001562180-20-001111-index.htm
2020-02-05Curran SimpsonSVP, Product Development & CTOSell5,637.0050.00281,850.0022,648.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm
2019-03-21Vittal VasistaChief Financial OfficerSell1,700.0061.31104,227.00229,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002018/0001562180-19-002018-index.htm
2020-01-08Vittal VasistaChief Financial OfficerSell2,400.0041.4099,360.00229,815.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm
2019-03-21Vittal VasistaChief Financial OfficerSell8,300.0060.64503,312.00230,915.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002018/0001562180-19-002018-index.htm
2018-12-03Kenneth T. MillsPresident and CEOSell1,300.0061.3379,729.00231,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004849/0001562180-18-004849-index.htm
2020-01-17Curran SimpsonSVP, Product Development & CTOSell5,922.0050.00296,100.0023,148.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm
2020-01-08Vittal VasistaChief Financial OfficerBuy3,000.0013.0939,270.00232,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000321/0001562180-20-000321-index.htm
2018-12-03Kenneth T. MillsPresident and CEOSell18,700.0060.341,128,358.00232,300.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004849/0001562180-18-004849-index.htm
2019-03-05Vittal VasistaChief Financial OfficerSell3,068.0060.01184,110.68239,215.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001801/0001562180-19-001801-index.htm
2019-12-09Curran SimpsonSVP, Product Development & CTOSell6,153.0044.26272,331.7823,948.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019006017/0001562180-19-006017-index.htm
2019-09-19Kenneth T. MillsPresident and CEOSell7,773.0039.91310,220.43241,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm
2019-02-07Vittal VasistaChief Financial OfficerBuy120,000.000.85102,000.00242,283.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000874/0001562180-19-000874-index.htm
2019-02-01Kenneth T. MillsPresident and CEOBuy45,000.000.8538,250.00246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000759/0001562180-19-000759-index.htm
2019-02-15Kenneth T. MillsPresident and CEOSell8,066.0047.84385,877.44246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm
2019-03-19Kenneth T. MillsPresident and CEOSell9,130.0058.74536,296.20246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm
2019-04-22Kenneth T. MillsPresident and CEOSell100.0053.055,305.00246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2019-05-20Kenneth T. MillsPresident and CEOSell300.0043.9913,197.00246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm
2019-06-19Kenneth T. MillsPresident and CEOSell4,120.0053.25219,390.00246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm
2019-07-19Kenneth T. MillsPresident and CEOSell2,300.0049.97114,931.00246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm
2019-08-19Kenneth T. MillsPresident and CEOSell376.0037.9214,257.92246,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm
2019-04-22Kenneth T. MillsPresident and CEOSell1,300.0052.3368,029.00246,100.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2019-05-20Kenneth T. MillsPresident and CEOSell10,559.0043.32457,415.88246,300.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm
2019-08-19Kenneth T. MillsPresident and CEOSell14,624.0037.54548,984.96246,376.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm
2019-04-22Kenneth T. MillsPresident and CEOSell3,270.0051.07166,998.90247,400.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2020-02-10DONALD J JR HAYDENDirectorBuy24,800.000.8521,080.0024,800.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001108/0001562180-20-001108-index.htm
2019-07-19Kenneth T. MillsPresident and CEOSell12,700.0049.40627,380.00248,300.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm
2019-09-19Kenneth T. MillsPresident and CEOSell2,227.0039.1987,276.13248,773.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm
2019-06-19Kenneth T. MillsPresident and CEOSell10,880.0052.27568,697.60250,120.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm
2019-04-22Kenneth T. MillsPresident and CEOSell6,929.0050.31348,597.99250,670.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2019-09-19Kenneth T. MillsPresident and CEOBuy5,000.000.854,250.00251,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004927/0001562180-19-004927-index.htm
2018-11-26Kenneth T. MillsPresident and CEOSell8,620.0064.64557,196.80251,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004726/0001562180-18-004726-index.htm
2019-02-15Kenneth T. MillsPresident and CEOSell3,522.0047.30166,590.60254,066.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm
2019-03-19Kenneth T. MillsPresident and CEOSell5,870.0058.21341,692.70255,130.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm
2020-01-17Curran SimpsonSVP, Product Development & CTOBuy1,622.0019.5031,629.0025,570.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm
2019-05-20Kenneth T. MillsPresident and CEOSell4,141.0042.08174,253.28256,859.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm
2019-09-12Patrick J. ChristmasSVP, General CounselSell5,486.0042.00230,412.002,572.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004820/0001562180-19-004820-index.htm
2019-02-15Kenneth T. MillsPresident and CEOSell3,412.0045.96156,815.52257,588.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm
2019-04-22Kenneth T. MillsPresident and CEOSell3,401.0049.29167,635.29257,599.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2020-02-05Curran SimpsonSVP, Product Development & CTOBuy2,708.0013.0935,447.7225,856.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm
2018-11-26Kenneth T. MillsPresident and CEOSell11,380.0063.81726,157.80259,620.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004726/0001562180-18-004726-index.htm
2018-11-19LUKE M BESHARDirectorBuy2,604.0049.45128,767.802,604.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2019-02-14Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001047/0001562180-19-001047-index.htm
2019-03-19Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002005/0001562180-19-002005-index.htm
2019-04-22Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002331/0001562180-19-002331-index.htm
2019-05-20Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003056/0001562180-19-003056-index.htm
2019-06-19Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003604/0001562180-19-003604-index.htm
2019-07-19Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004035/0001562180-19-004035-index.htm
2019-08-19Kenneth T. MillsPresident and CEOBuy15,000.000.8512,750.00261,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004433/0001562180-19-004433-index.htm
2018-11-07Patrick J. ChristmasSVP, General CounselSell15,000.0072.061,080,900.002,669.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004476/0001562180-18-004476-index.htm
2018-12-18Patrick J. ChristmasSVP, General CounselSell720.0048.9735,258.402,669.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm
2020-02-05Curran SimpsonSVP, Product Development & CTOBuy1,000.0019.5019,500.0026,856.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm
2020-02-10Curran SimpsonSVP, Product Development & CTOBuy4,253.0019.5082,933.5026,901.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2018-11-21Kenneth T. MillsPresident and CEOSell6,898.0061.92427,124.16271,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm
2018-11-21Kenneth T. MillsPresident and CEOSell6,802.0061.22416,418.44277,898.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm
2020-02-05Curran SimpsonSVP, Product Development & CTOBuy958.0022.0021,076.0027,814.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm
2020-01-17Curran SimpsonSVP, Product Development & CTOBuy2,700.0022.0059,400.0028,270.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm
2020-02-05Curran SimpsonSVP, Product Development & CTOBuy471.0035.8016,861.8028,285.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001015/0001562180-20-001015-index.htm
2018-11-21Kenneth T. MillsPresident and CEOSell1,300.0060.0978,117.00284,700.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004678/0001562180-18-004678-index.htm
2018-11-12Kenneth T. MillsPresident and CEOSell200.0064.3012,860.00286,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm
2018-11-12Kenneth T. MillsPresident and CEOSell6,214.0063.65395,521.10286,200.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm
2020-01-17Curran SimpsonSVP, Product Development & CTOBuy800.0035.8028,640.0029,070.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000454/0001562180-20-000454-index.htm
2018-11-12Kenneth T. MillsPresident and CEOSell13,586.0062.85853,880.10292,414.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004532/0001562180-18-004532-index.htm
2020-01-14DONALD J JR HAYDENDirectorBuy30,000.000.8525,500.0030,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000391/0001562180-20-000391-index.htm
2018-12-31Patrick J. ChristmasSVP, General CounselBuy337.0035.6612,016.583,006.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000222/0001562180-19-000222-index.htm
2019-04-18Patrick J. ChristmasSVP, General CounselSell100.0055.505,550.003,006.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2019-06-18Patrick J. ChristmasSVP, General CounselSell100.0054.755,475.003,006.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm
2019-12-09Curran SimpsonSVP, Product Development & CTOSell9,399.0043.40407,916.6030,101.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019006017/0001562180-19-006017-index.htm
2019-06-30Patrick J. ChristmasSVP, General CounselBuy52.0036.831,915.163,058.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm
2019-07-18Patrick J. ChristmasSVP, General CounselSell100.0050.005,000.003,058.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm
2019-07-19Patrick J. ChristmasSVP, General CounselSell4,900.0050.03245,147.003,058.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm
2018-11-05Kenneth T. MillsPresident and CEOSell4,709.0069.92329,253.28306,000.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm
2019-04-18Patrick J. ChristmasSVP, General CounselSell885.0054.6648,374.103,106.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2019-06-18Patrick J. ChristmasSVP, General CounselSell1,934.0053.29103,062.863,106.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm
2018-11-05Kenneth T. MillsPresident and CEOSell3,340.0069.47232,029.80310,709.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm
2018-11-05Kenneth T. MillsPresident and CEOSell3,635.0068.27248,161.45314,049.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm
2019-07-18Patrick J. ChristmasSVP, General CounselBuy100.0019.501,950.003,158.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm
2018-11-05Kenneth T. MillsPresident and CEOSell4,816.0067.16323,442.56317,684.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm
2020-01-17DONALD J JR HAYDENDirectorBuy3,200.000.852,720.003,200.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020000452/0001562180-20-000452-index.htm
2018-11-05Kenneth T. MillsPresident and CEOSell3,500.0066.29232,015.00322,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004451/0001562180-18-004451-index.htm
2018-12-18Patrick J. ChristmasSVP, General CounselSell2,055.0047.8598,331.753,389.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm
2020-02-11Curran SimpsonSVP, Product Development & CTOSell3,692.0051.37189,658.043,948.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2018-11-16Curran SimpsonSVP, Technical OperationsSell15,494.0064.711,002,616.7439,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm
2019-02-05Curran SimpsonSVP, Product Development & CTOSell43,832.0050.082,195,106.5639,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm
2019-02-25Curran SimpsonSVP, Product Development & CTOSell5,300.0054.05286,465.0039,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001472/0001562180-19-001472-index.htm
2019-05-28Curran SimpsonSVP, Product Development & CTOSell18,000.0050.00900,000.0039,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003180/0001562180-19-003180-index.htm
2019-04-18Patrick J. ChristmasSVP, General CounselSell1,115.0053.6759,842.053,991.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2020-02-10Curran SimpsonSVP, Product Development & CTOBuy14,928.0022.00328,416.0041,829.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2019-02-25Curran SimpsonSVP, Product Development & CTOBuy5,300.0035.80189,740.0044,800.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001472/0001562180-19-001472-index.htm
2018-11-05Stephen YooChief Medical OfficerSell3,854.0069.54268,007.164,627.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2018-11-20LUKE M BESHARDirectorBuy4,688.0022.00103,136.004,688.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2019-02-05Curran SimpsonSVP, Product Development & CTOBuy8,450.0035.80302,510.0047,950.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm
2019-06-18Patrick J. ChristmasSVP, General CounselSell2,966.0052.74156,426.845,040.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm
2018-12-03Stephen YooChief Medical OfficerSell13,053.0060.35787,748.55507.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004850/0001562180-18-004850-index.htm
2019-04-18Patrick J. ChristmasSVP, General CounselSell2,900.0052.55152,395.005,106.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2020-02-10Curran SimpsonSVP, Product Development & CTOBuy12,479.0035.80446,748.2054,308.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2018-12-18Patrick J. ChristmasSVP, General CounselSell2,225.0046.79104,107.755,444.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm
2018-11-16Curran SimpsonSVP, Technical OperationsSell6,505.0063.64413,978.2054,994.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm
2018-11-27LUKE M BESHARDirectorBuy4,687.0022.00103,114.005,570.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2019-05-28Curran SimpsonSVP, Product Development & CTOBuy18,000.0022.00396,000.0057,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003180/0001562180-19-003180-index.htm
2018-11-19LUKE M BESHARDirectorSell600.0062.8137,686.00600.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2018-11-16Curran SimpsonSVP, Technical OperationsSell6,883.0062.79432,183.5761,499.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm
2018-11-19Stephen YooChief Medical OfficerSell9,092.0059.61541,974.126,261.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004642/0001562180-18-004642-index.htm
2019-03-12Olivier DanosChief Scientific OfficerBuy5,000.0020.35101,750.006,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019001906/0001562180-19-001906-index.htm
2019-04-15Olivier DanosChief Scientific OfficerSell1,000.0053.0953,090.006,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm
2019-04-18Patrick J. ChristmasSVP, General CounselBuy3,541.0012.1042,846.106,547.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2018-11-16Curran SimpsonSVP, Technical OperationsSell4,000.0061.91247,640.0068,382.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm
2018-11-16Curran SimpsonSVP, Technical OperationsBuy32,882.0022.00723,404.0072,382.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004631/0001562180-18-004631-index.htm
2019-04-15Olivier DanosChief Scientific OfficerSell1,000.0052.2352,230.007,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm
2020-02-11Curran SimpsonSVP, Product Development & CTOSell8,872.0050.13444,753.367,640.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm
2018-12-18Patrick J. ChristmasSVP, General CounselBuy5,000.0012.1060,500.007,669.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018005060/0001562180-18-005060-index.htm
2018-11-20LUKE M BESHARDirectorBuy2,988.0012.7438,067.127,676.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2019-07-19Patrick J. ChristmasSVP, General CounselBuy4,900.0019.5095,550.007,958.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004025/0001562180-19-004025-index.htm
2019-04-18Patrick J. ChristmasSVP, General CounselBuy1,459.0019.5028,450.508,006.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002324/0001562180-19-002324-index.htm
2019-06-18Patrick J. ChristmasSVP, General CounselBuy5,000.0012.1060,500.008,006.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019003602/0001562180-19-003602-index.htm
2019-09-12Patrick J. ChristmasSVP, General CounselBuy5,000.0012.1060,500.008,058.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019004820/0001562180-19-004820-index.htm
2019-02-05Curran SimpsonSVP, Product Development & CTOBuy32,882.0022.00723,404.0080,832.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm
2019-02-05Curran SimpsonSVP, Product Development & CTOBuy1,875.0019.5036,562.5082,707.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm
2019-02-05Curran SimpsonSVP, Product Development & CTOBuy625.0013.098,181.2583,332.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019000815/0001562180-19-000815-index.htm
2018-11-05Stephen YooChief Medical OfficerSell3,700.0068.22252,414.008,481.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004452/0001562180-18-004452-index.htm
2019-04-15Olivier DanosChief Scientific OfficerBuy2,000.0020.3540,700.008,500.00https://www.sec.gov/Archives/edgar/data/1590877/000156218019002295/0001562180-19-002295-index.htm
2018-11-27LUKE M BESHARDirectorBuy883.0049.4543,664.35883.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004727/0001562180-18-004727-index.htm
2018-11-19LUKE M BESHARDirectorBuy6,250.0018.85117,812.508,854.00https://www.sec.gov/Archives/edgar/data/1590877/000156218018004643/0001562180-18-004643-index.htm
2020-02-10Curran SimpsonSVP, Product Development & CTOSell44,429.0050.222,231,224.389,879.00https://www.sec.gov/Archives/edgar/data/1590877/000156218020001112/0001562180-20-001112-index.htm